BiotechTube
Home/Slam BioTherapeutics/Chan Whiting, PhD
CW

Chan Whiting, PhD

Chief Scientific Officer

Slam BioTherapeutics

Therapeutic Areas

OncologyHematology

Slam BioTherapeutics Pipeline

DrugIndicationPhase
SLM124MDS, AML, CTCL, FLPreclinical

Leadership Team at Slam BioTherapeutics

RH
Rick Heinick
CEO and Chairman
DS
Dr. Steven Rosen
SAB Chair and Co-Founder
View full Slam BioTherapeutics profile